Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "3-dihydro-1H-indole-5-sulfonamide)"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
The Blocking of c-Met Signaling Induces Apoptosis through the Increase of p53 Protein in Lung Cancer
Hae-Yun Jung, Hyun-Jung Joo, Jong Kuk Park, Yeul Hong Kim
Cancer Res Treat. 2012;44(4):251-261.   Published online December 31, 2012
DOI: https://doi.org/10.4143/crt.2012.44.4.251
AbstractAbstract PDFPubReaderePub
PURPOSE
c-Met is an attractive potential target for novel therapeutic inhibition of human cancer, and c-Met tyrosine kinase inhibitors (TKIs) are effective growth inhibitors of various malignancies. However, their mechanisms in anticancer effects are not clear. In the present study, we investigated the possibility that blocking c-Met signaling induces p53-mediated growth inhibition in lung cancer.
MATERIALS AND METHODS
The growth inhibitory effects of c-Met TKI (SU11274) on lung cancer cells and a xenograft model were assessed using the MTT assay, flow cytometry, and terminal deoxyribonucleotide transferase-mediated nick-end labeling staining. The role of p53 protein in the sensitivity of c-Met TKI (SU11274) was examined by Western blot analysis and immunohistochemistry.
RESULTS
SU11274 significantly induced apoptosis in A549 cells with wild-type p53, compared with that in Calu-1 cells with null-type p53. SU11274 increased p53 protein by enhancing the stability of p53 protein. Increased p53 protein by SU11274 induced up-regulation of Bax and PUMA expression and down-regulation of Bcl-2 expression, subsequently activating caspase 3. In p53 knock-out and knock-in systems, we confirmed that SU11274 caused apoptosis through the p53-mediated apoptotic pathway. Likewise, in the A549 xenograft model, SU11274 effectively shrank tumor volume and induced apoptosis via increased p53 protein expression. Blocking c-Met signaling increased the level of p53 protein.
CONCLUSION
Our finding suggested that p53 plays an important role in SU11274-induced apoptosis, and p53 status seems to be related to the sensitivity to SU11274 in lung cancer.

Citations

Citations to this article as recorded by  
  • Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents
    Bassem H. Naguib, Heba A. Elsebaie, Mohamed S. Nafie, Samy Mohamady, Nader R. Albujuq, Aya Samir Ayed, Dina Nada, Ahmed F. Khalil, Salma M. Hefny, Haytham O. Tawfik, Moataz A. Shaldam
    Bioorganic Chemistry.2024; 151: 107682.     CrossRef
  • A Boolean Model of the Proliferative Role of the lncRNA XIST in Non-Small Cell Lung Cancer Cells
    Shantanu Gupta, Daner A. Silveira, Ronaldo F. Hashimoto, Jose Carlos M. Mombach
    Biology.2022; 11(4): 480.     CrossRef
  • Artonin F Induces the Ubiquitin-Proteasomal Degradation of c-Met and Decreases Akt-mTOR Signaling
    Rapeepun Soonnarong, Ismail Dwi Putra, Nicharat Sriratanasak, Boonchoo Sritularak, Pithi Chanvorachote
    Pharmaceuticals.2022; 15(5): 633.     CrossRef
  • Targeted inhibition of c-MET by podophyllotoxin promotes caspase-dependent apoptosis and suppresses cell growth in gefitinib-resistant non-small cell lung cancer cells
    Ha-Na Oh, Ah-Won Kwak, Mee-Hyun Lee, Eunae Kim, Goo Yoon, Seung-Sik Cho, Kangdong Liu, Jung-Il Chae, Jung-Hyun Shim
    Phytomedicine.2021; 80: 153355.     CrossRef
  • Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung
    Dongli Xie, Xiaogang Luo
    Toxicology and Applied Pharmacology.2021; 412: 115391.     CrossRef
  • Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer
    Fatemeh Moosavi, Elisa Giovannetti, Godefridus J. Peters, Omidreza Firuzi
    Critical Reviews in Oncology/Hematology.2021; 160: 103234.     CrossRef
  • Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple‐negative breast cancer
    Thomas D. Wright, Christopher Raybuck, Akshita Bhatt, Darlene Monlish, Suravi Chakrabarty, Katy Wendekier, Nathan Gartland, Mohit Gupta, Matthew E. Burow, Patrick T. Flaherty, Jane E. Cavanaugh
    Journal of Cellular Biochemistry.2020; 121(2): 1156.     CrossRef
  • The role of NF-κB and AhR transcription factors in lead-induced lung toxicity in human lung cancer A549 cells
    Ibraheem M. Attafi, Saleh A. Bakheet, Hesham M. Korashy
    Toxicology Mechanisms and Methods.2020; 30(3): 197.     CrossRef
  • Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action
    Khaled AbouAitah, Anna Swiderska-Sroda, Ahmed A. Farghali, Jacek Wojnarowicz, Agata Stefanek, Stanislaw Gierlotka, Agnieszka Opalinska, Abdou K. Allayeh, Tomasz Ciach, Witold Lojkowski
    Oncotarget.2018; 9(41): 26466.     CrossRef
  • Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression
    Yang Chen, Qin Zhang, Qiuyan Wang, Jie Li, Csilla Sipeky, Jihan Xia, Ping Gao, Yanling Hu, Haiying Zhang, Xiaobo Yang, Haitao Chen, Yonghua Jiang, Yuehong Yang, Ziting Yao, Yinchun Chen, Yong Gao, Aihua Tan, Ming Liao, Johanna Schleutker, Jianfeng Xu, Yin
    Scientific Reports.2017;[Epub]     CrossRef
  • Regulation of theMEToncogene: molecular mechanisms
    Jack Zhang, Andy Babic
    Carcinogenesis.2016; 37(4): 345.     CrossRef
  • The RTK/ERK pathway is associated with prostate cancer risk on the SNP level: A pooled analysis of 41 sets of data from case–control studies
    Yang Chen, Tianyu Li, Xiaoqiang Yu, Jianfeng Xu, Jianling Li, Dexiang Luo, Zengnan Mo, Yanling Hu
    Gene.2014; 534(2): 286.     CrossRef
  • miR-210 over-expression enhances mesenchymal stem cell survival in an oxidative stress environment through antioxidation and c-Met pathway activation
    JianFeng Xu, ZheYong Huang, Li Lin, MingQiang Fu, YanHua Gao, YunLi Shen, YunZeng Zou, AiJun Sun, JuYing Qian, JunBo Ge
    Science China Life Sciences.2014; 57(10): 989.     CrossRef
  • Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2
    Mario Acunzo, Giulia Romano, Dario Palmieri, Alessandro Laganá, Michela Garofalo, Veronica Balatti, Alessandra Drusco, Mario Chiariello, Patrick Nana-Sinkam, Carlo M. Croce
    Proceedings of the National Academy of Sciences.2013; 110(21): 8573.     CrossRef
  • Gold nanoparticles trigger apoptosis and necrosis in lung cancer cells with low intracellular glutathione
    Min Liu, Xiaohu Gu, Ke Zhang, Yi Ding, Xinbing Wei, Xiumei Zhang, Yunxue Zhao
    Journal of Nanoparticle Research.2013;[Epub]     CrossRef
  • RTK/ERK Pathway under Natural Selection Associated with Prostate Cancer
    Yang Chen, Xianxiang Xin, Jie Li, Jianfeng Xu, Xiaoxiang Yu, Tianyu Li, Zengnan Mo, Yanling Hu, Antimo Migliaccio
    PLoS ONE.2013; 8(11): e78254.     CrossRef
  • 13,126 View
  • 71 Download
  • 16 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP